Ethyl 2-(5-chloropyridin-2-yl)acetate

Catalog No. :
ACOTEZ463
CAS No. :
1060814-82-5
Molecular Formula :
C9H10ClNO2
Molecular Weight :
199.64

IUPAC Name:ethyl 2-(5-chloropyridin-2-yl)acetate

Ethyl 2-(5-chloropyridin-2-yl)acetate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$54.00Login to see priceIn stockIn stock
250mg95%$84.00Login to see priceIn stockIn stock
1g95%$195.00Login to see priceInquiryIn stock
5g95%$772.00Login to see priceInquiryInquiry
25g95%$3088.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameEthyl 2-(5-chloropyridin-2-yl)acetate
IUPAC Nameethyl 2-(5-chloropyridin-2-yl)acetate
MDL No.MFCD10698594
Molecular FormulaC9H10ClNO2
Molecular Weight199.64
SMILESO=C(OCC)CC1=NC=C(Cl)C=C1
InChI KeyMAFCWRXNUIZGKW-UHFFFAOYSA-N
Synonymethyl 2-(5-chloropyridin-2-yl)acetate;ETHYL (5-CHLOROPYRIDIN-2-YL)ACETATE;(5-Chloro-pyridin-2-yl)-acetic acid ethyl ester;2-Pyridineacetic acid, 5-chloro-, ethyl ester
CAS No.1060814-82-5
PubChem CID55263201

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACOTEZ463 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACMOZX619 route compound structure diagram
    ACMOZX61940473-01-6 In Stock
  4. Then
  5. ACOTEZ463 route product structure diagram
    ACOTEZ4631060814-82-5 In Stock
Inquiry

2. ACOTEZ463 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACTRMX927 route compound structure diagram
    ACTRMX927555-75-9
  2. Plus
  3. ACIOSB184 route compound structure diagram
    ACIOSB1841000522-43-9 In Stock
  4. Then
  5. ACOTEZ463 route product structure diagram
    ACOTEZ4631060814-82-5 In Stock
Inquiry

Comments (0)